Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) - PAR-25-064
Funder
National Institutes of Health
LOI Required
No
Application Deadline
;
;
;
Maximum Project Duration
2 years
Research Focus Areas
Alzheimer’s Disease, Dementia, and Neurocognitive Disorders
Pharmacology
Pharmacotherapy
Neurobiology/Neuroscience
Population Focus
Older Adults
Research Methods
Randomized Control Trials (RCT)
Neural Networks
Description
The goal of this Notice of Funding Opportunity (NOFO) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRD.